Literature DB >> 6849735

Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid.

D J Birkett, J O Miners, J Attwood.   

Abstract

The route of formation of 1-methyluric acid (1MU) from theophylline has been investigated by i.v. administration of 1-methylxanthine (1MX) before and after allopurinol treatment and of 1,3-dimethyluric acid (1,3DMU) to healthy male volunteers. 1,3DMU was recovered unchanged in urine and was not demethylated to 1MU. By contrast after administration of 1MX the major part of the dose was recovered as 1MU. After allopurinol this was reversed with most of the 1MX dose being excreted unchanged and only a minor amount as 1MU. The results show that 1MU derived from theophylline is formed by an initial 3-demethylation to 1MX and then a rapid xanthine oxidase mediated 8-oxidation. No 1MU is formed by 3-demethylation of 1,3DMU.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849735      PMCID: PMC1427820          DOI: 10.1111/j.1365-2125.1983.tb01475.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  A study of the metabolism of theobromine, theophylline, and caffeine in man.

Authors:  H H CORNISH; A A CHRISTMAN
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

2.  Studies on uric acid and related compounds. III. Observations on the specificity of mammalian xanthine oxidases.

Authors:  F BERGMANN; S DIKSTEIN
Journal:  J Biol Chem       Date:  1956-12       Impact factor: 5.157

3.  Relationship of urinary metabolites of theophylline to serum theophylline levels.

Authors:  J W Jenne; H T Nagasawa; R D Thompson
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

4.  Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography.

Authors:  R D Thompson; H T Nagasawa; J W Jenne
Journal:  J Lab Clin Med       Date:  1974-10

5.  A comparison of the specificities of xanthine oxidase and aldehyde oxidase.

Authors:  T A Krenitsky; S M Neil; G B Elion; G H Hitchings
Journal:  Arch Biochem Biophys       Date:  1972-06       Impact factor: 4.013

6.  Theophylline metabolism by the rat liver microsomal system.

Authors:  S M Lohmann; R P Miech
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

7.  Effects of allopurinol on theophylline metabolism and clearance.

Authors:  J J Grygiel; L M Wing; J Farkas; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

8.  Theophylline pharmacokinetics in advanced age.

Authors:  E J Antal; P A Kramer; S A Mercik; D J Chapron; I R Lawson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

  8 in total
  20 in total

1.  A study on the route of 1-methylurate formation in theophylline metabolism.

Authors:  C Bayar; I Ozer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

2.  Comparison of the urinary metabolite profile of caffeine in young and elderly males.

Authors:  J Blanchard; S J Sawers; J H Jonkman; D D Tang-Liu
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

3.  Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

Authors:  R O Day; J O Miners; D J Birkett; A Whitehead; D Naidoo; J Hayes; E Savdie
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

4.  Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.

Authors:  R O Day; J Miners; D J Birkett; G G Graham; A Whitehead
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

5.  Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.

Authors:  S Dadashzadeh; H Tajerzaden
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

6.  Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.

Authors:  J O Miners; L M Wing; K J Lillywhite; R A Robson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

Review 7.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.

Authors:  M Sarkar; R E Polk; P S Guzelian; C Hunt; H T Karnes
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

9.  1-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.

Authors:  D J Birkett; J O Miners; R O Day
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

10.  Pharmacokinetics of theophylline and its metabolites in rabbits.

Authors:  A Celardo; G L Traina; A Jankowski; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.